ATE209496T1 - Verfahren zum herstellen von fusidinsäuretabletten - Google Patents

Verfahren zum herstellen von fusidinsäuretabletten

Info

Publication number
ATE209496T1
ATE209496T1 AT95927705T AT95927705T ATE209496T1 AT E209496 T1 ATE209496 T1 AT E209496T1 AT 95927705 T AT95927705 T AT 95927705T AT 95927705 T AT95927705 T AT 95927705T AT E209496 T1 ATE209496 T1 AT E209496T1
Authority
AT
Austria
Prior art keywords
fusidic acid
producing
acid tablets
tablets
tabletting
Prior art date
Application number
AT95927705T
Other languages
English (en)
Inventor
Erik Preben Rasmussen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Application granted granted Critical
Publication of ATE209496T1 publication Critical patent/ATE209496T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT95927705T 1994-07-26 1995-07-21 Verfahren zum herstellen von fusidinsäuretabletten ATE209496T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9415048A GB9415048D0 (en) 1994-07-26 1994-07-26 Tablet
PCT/EP1995/002904 WO1996003128A1 (en) 1994-07-26 1995-07-21 Preparation of fusidic acid tablets

Publications (1)

Publication Number Publication Date
ATE209496T1 true ATE209496T1 (de) 2001-12-15

Family

ID=10758888

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95927705T ATE209496T1 (de) 1994-07-26 1995-07-21 Verfahren zum herstellen von fusidinsäuretabletten

Country Status (20)

Country Link
EP (1) EP0773783B1 (de)
JP (1) JP3853358B2 (de)
KR (1) KR100358614B1 (de)
CN (1) CN1070703C (de)
AT (1) ATE209496T1 (de)
AU (1) AU681980B2 (de)
CA (1) CA2193235C (de)
CZ (1) CZ286197B6 (de)
DE (1) DE69524226T2 (de)
DK (1) DK0773783T3 (de)
ES (1) ES2163521T3 (de)
FI (1) FI117666B (de)
GB (1) GB9415048D0 (de)
HU (1) HU221483B (de)
NZ (1) NZ290806A (de)
PL (1) PL180935B1 (de)
PT (1) PT773783E (de)
RO (1) RO118633B1 (de)
RU (1) RU2140272C1 (de)
WO (1) WO1996003128A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9022098A (en) * 1997-08-20 1999-03-08 Fuisz Technologies Ltd. Process for improving flow and compression of tableting compositions
AU2006310873B2 (en) 2005-10-31 2012-05-24 Leo Pharma A/S Preparation of an antibiotic crystalline fusidic acid
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
JP5249568B2 (ja) * 2007-12-06 2013-07-31 旭化成ケミカルズ株式会社 成形用粉末、およびこれを用いた圧縮成形組成物、ならびに成形用粉末の製造方法
DE102008051783A1 (de) * 2008-10-17 2010-04-22 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Valsartan enthaltende Tablette
EP2382968A1 (de) 2010-03-26 2011-11-02 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Partikel Groesse Verteilung von Fusidinsäure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7411402A (nl) * 1973-09-13 1975-03-17 Leo Pharm Prod Ltd Werkwijze voor het bereiden van een middel tegen arthritis.
EP0300073A1 (de) * 1987-07-22 1989-01-25 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Verwendung von Fusidinsäure zur Behandlung von dem Aids verwandten Komplexen und Aids im Endstadium

Also Published As

Publication number Publication date
CN1154066A (zh) 1997-07-09
NZ290806A (en) 1998-01-26
AU681980B2 (en) 1997-09-11
PL318261A1 (en) 1997-05-26
PL180935B1 (pl) 2001-05-31
HU221483B (en) 2002-10-28
CA2193235A1 (en) 1996-02-08
CN1070703C (zh) 2001-09-12
CZ22997A3 (en) 1997-04-16
KR100358614B1 (ko) 2003-01-10
HUT76836A (en) 1997-11-28
AU3164495A (en) 1996-02-22
RO118633B1 (ro) 2003-08-29
GB9415048D0 (en) 1994-09-14
FI965214A (fi) 1996-12-27
EP0773783B1 (de) 2001-11-28
HU9700217D0 (en) 1997-04-28
DE69524226T2 (de) 2002-06-27
FI965214A0 (fi) 1996-12-27
CZ286197B6 (cs) 2000-02-16
KR970704447A (ko) 1997-09-06
JPH10502937A (ja) 1998-03-17
DK0773783T3 (da) 2002-04-02
ES2163521T3 (es) 2002-02-01
WO1996003128A1 (en) 1996-02-08
EP0773783A1 (de) 1997-05-21
FI117666B (fi) 2007-01-15
RU2140272C1 (ru) 1999-10-27
JP3853358B2 (ja) 2006-12-06
CA2193235C (en) 2008-03-18
PT773783E (pt) 2002-04-29
DE69524226D1 (de) 2002-01-10

Similar Documents

Publication Publication Date Title
YU49069B (sh) Postupak za pravljenje formulacije tablete
GEP20012580B (en) Substituted 4-Hydroxy-Phenylalcanoic Acid Derivatives With Agonist Activity to PPAR-Gamma, Methods for Their Production, Pharmaceutical Conposition and Methods for Treatment
ES2156997T3 (es) Proceso nuevo para la produccion de sal calcica del acido amorfo (r-(r*,r*))-2-(4-fluorofenil)-beta,delta-dihidroxi-5-(1-metiletil)-3-fenil-4-((fenilamino)carbonil)-1h-pirrol-1-heptanoico (2:1).
IL135130A0 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
ATE101340T1 (de) Neue arzneimittelformulierung sowie verfahren zu deren herstellung.
BR0013885A (pt) Comprimidos aperfeiçoados
CY1674A (en) 3-(5-aminopentyl)-amino-1-benzazepin-2-one-1-alcanoic acids,process for their preparation,their pharmaceutical preparation as well their therapeutic use
NZ337211A (en) Method of treating inflammatory, HIV diseases by using peptidyl boronic acid ester and acid compounds as proteasome inhibitors
DE58900594D1 (de) Ibuprofen-brausezubereitungen.
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
CA2280310A1 (en) Nmda antagonist
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
DE69524226D1 (de) Verfahren zum herstellen von fusidinsäuretabletten
DE69616072D1 (de) Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung
AU9164291A (en) Method to produce sodium citrate using electrodialysis
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
BE876909A (fr) Sel sodique de mercaptopropionylglycine, procede pour sa preparation et utilisations therapeutiques
MA23930A1 (fr) Procede de production de granules pharmaceutiques
WO2001034553A3 (en) 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
MX9704621A (es) Amidas de acido 4-amino-2-ureido-pirimidin-5-carboxilico, procedimientos para su preparacion, medicamentos que contienen estos compuestos, y su utilizacion.
MX9704257A (es) Proceso para la preparacion de compuestos de 5-(alcoximetil) -2,3-piridinodicarboximida.
ECSP961662A (es) Nueva composicion farmaceutica que contiene trimebutina y proceso para su preparacion
IT1295148B1 (it) Procedimento per la costruzione di calchi da usare nel procedimento per formare oggetti in resina riproducenti un modello, come statuette
RU97115885A (ru) Способ лечения хронических неспецифических воспалительных заболеваний легких
IT8920318A0 (it) Composti otticamente attivi utili nel trattamento dell'edema polmonare e delle crisi ipertensive, un processo per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification